A Review of Treatment Approaches for Spinal Cord Injury Improvement DOI Creative Commons

Mohammad Amin Jafarimanesh,

Jafar Ai,

Shahrokh Shojae

et al.

The Neuroscience Journal of Shefaye Khatam, Journal Year: 2023, Volume and Issue: 12(1), P. 111 - 120

Published: Dec. 1, 2023

Language: Английский

ROS-scavenging lipid-based liquid crystalline as a favorable stem cell extracellular vesicles delivery vector to promote wound healing DOI
Lijun Li, Ying Wang, Yuqi Xu

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 371, P. 298 - 312

Published: June 3, 2024

Language: Английский

Citations

11

A cryo-shocked M2 macrophages based treatment strategy promoting repair of spinal cord injury via immunomodulation and axonal regeneration effects DOI Creative Commons

Ermei Lu,

Kecheng Zhou,

Jiansen Miao

et al.

Journal of Nanobiotechnology, Journal Year: 2025, Volume and Issue: 23(1)

Published: Jan. 6, 2025

Recovery from spinal cord injury (SCI) is often impeded by neuroinflammation, scar formation, and limited axonal regeneration. To tackle these issues, we developed an innovative biomimetic drug delivery system using liquid nitrogen-treated M2 macrophages (LNT M2) which internalized paclitaxel (PTX) nanoparticles beforehand. These were incorporated into a gelatin methacryloyl (GelMA) scaffold, creating multifunctional, injectable treatment for single-dose administration. The LNT inherited the inflammatory factor/chemokine receptors living thus possessing significant neutralizing effect. In addition, scaffold provides slow, sustained release of PTX, promoting regeneration suppressing formation in SCI rats. M2-based dual-functional significantly enhances motor function, reduces accelerates modulating microenvironment preventing glial fibrotic scars. This approach combines regenerative effects low-dose PTX with immunoregulatory properties M2, leading to remarkable neurological recovery Moreover, scaffold's straightforward preparation, ease standardization, "ready-to-use" nature make it promising candidate acute intervention future clinical applications.

Language: Английский

Citations

1

Stem Cell-Derived Extracellular Vesicle-Mediated Therapeutic Signaling in Spinal Cord Injury DOI Open Access
Raju Poongodi,

Yung‐Wei Hsu,

Tao-Hsiang Yang

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(2), P. 723 - 723

Published: Jan. 16, 2025

Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising therapeutic strategy for spinal cord injury (SCI). These nanosized possess unique properties such low immunogenicity and the ability to cross biological barriers, making them ideal carriers delivering bioactive molecules injured tissues. MSC-EVs been demonstrated exert multiple beneficial effects in SCI, including reducing inflammation, promoting neuroprotection, enhancing axonal regeneration. Recent studies delved into molecular mechanisms underlying MSC-EV-mediated effects. Exosomal microRNAs (miRNAs) identified key regulators of various cellular processes involved SCI pathogenesis repair. miRNAs can influence oxidative stress, apoptosis by modulating gene expression. This review summarized current state MSC-EV-based therapies highlighting potential clinical applications. We discussed challenges limitations translating these practice, inconsistent EV production, complex cargo composition, need targeted delivery strategies. Future research should focus on optimizing production characterization, identifying miRNAs, developing innovative systems maximize SCI.

Language: Английский

Citations

1

Role of Stem Cell-Derived Exosomes and microRNAs in Spinal Cord Injury DOI Open Access
Jinsu Hwang, Sujeong Jang, Choonghyo Kim

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(18), P. 13849 - 13849

Published: Sept. 8, 2023

Neurological disorders represent a global health problem. Current pharmacological treatments often lead to short-term symptomatic relief but have dose-dependent side effects, such as inducing orthostatic arterial hypotension due the blockade of alpha receptors, cardiotoxic effects impaired repolarization, and atrioventricular block tachycardia, including ventricular fibrillation. These challenges driven medical community seek effective for this serious threat. Mesenchymal stem cells (MSCs) are pluripotent with anti-inflammatory, anti-apoptotic, immunomodulatory properties, providing promising alternative their ability differentiate, favorable culture conditions, in vitro manipulation ability, robust properties. Although MSCs themselves rarely differentiate into neurons at site injury after transplantation vivo, paracrine factors secreted by can create environmental conditions cell-to-cell communication shown therapeutic effects. Recent studies that pleiotropic MSCs, particularly potential, be attributed primarily these factors. Exosomes derived from known play an important role Many evaluated potential exosome-based therapies treatment various neurological diseases. In addition exosomes, miRNAs been identified regulate genes alleviate neuropathological changes neurodegenerative This review explores burgeoning field therapies, focusing on MSC-derived exosomes exosomal miRNAs, summarizes recent findings shed light disorders. The insights gained may pave way innovative complex conditions. Furthermore, we suggest which rescue spinal cord via diverse signaling pathways.

Language: Английский

Citations

14

Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions DOI Creative Commons
Hye Kyu Choi,

Meizi Chen,

Li Ling Goldston

et al.

Nano Convergence, Journal Year: 2024, Volume and Issue: 11(1)

Published: May 13, 2024

Abstract Central Nervous System (CNS) disorders represent a profound public health challenge that affects millions of people around the world. Diseases such as Alzheimer’s disease (AD), Parkinson’s (PD), and traumatic brain injury (TBI) exemplify complexities diversities complicate their early detection development effective treatments. Amid these challenges, emergence nanotechnology extracellular vesicles (EVs) signals new dawn for treating diagnosing CNS ailments. EVs are cellularly derived lipid bilayer nanosized particles pivotal in intercellular communication within have potential to revolutionize targeted therapeutic delivery identification novel biomarkers. Integrating with amplifies diagnostic capabilities, opening avenues managing diseases. This review focuses on examining fascinating interplay between theranostics. Through highlighting remarkable advancements unique methodologies, we aim offer valuable perspectives how approaches can bring about revolutionary change management. The objective is harness distinctive attributes forge personalized, efficient interventions disorders, thereby providing beacon hope affected individuals. In short, confluence heralds promising frontier impactful treatments against diseases, which continue pose significant challenges. By focusing personalized powerful methods, might improve quality patients.

Language: Английский

Citations

5

Decellularized extracellular matrix in the treatment of spinal cord injury DOI Open Access

Wenwei Jiang,

Xuanxuan Zhang,

Shumin Yu

et al.

Experimental Neurology, Journal Year: 2023, Volume and Issue: 368, P. 114506 - 114506

Published: Aug. 18, 2023

Language: Английский

Citations

12

From hope to healing: Exploring the therapeutic potential of exosomes in spinal cord injury DOI Creative Commons
Nidhi Singh, Lahanya Guha, Hemant Kumar

et al.

Extracellular Vesicle, Journal Year: 2024, Volume and Issue: 3, P. 100044 - 100044

Published: May 13, 2024

Spinal cord injury (SCI) is the damage to spinal causing paralysis below site compromised patient life quality. Exosomes are nanosized vesicles released during physiological or pathological processes. They present a promising avenue for therapeutic drug delivery due their tissue specificity and biocompatibility, offering enhanced efficacy with reduced accumulation-based toxicity. In SCI, exosomes target inflammation, apoptosis, microglial polarization, autophagy, contributing interventions. This article comprehensively explores pathophysiology of diverse exosome synthesis processes, limitations challenges overcome, potential from various cellular sources in SCI treatment.

Language: Английский

Citations

4

Mapping the Knowledge Landscape of and Emerging Future Trends in Stem Cell Therapy for Osteoarthritis: A Bibliometric Analysis of the Literature From 1998 to 2024 DOI Creative Commons
Zhihong Meng, Dongmei He, Wang Hong-gang

et al.

Journal of Multidisciplinary Healthcare, Journal Year: 2025, Volume and Issue: Volume 18, P. 1281 - 1295

Published: March 1, 2025

The purpose of this study was to conduct a bibliometric analysis the literature on stem cell therapy for osteoarthritis (OA) visualize recent developments, identify hot spots, and determine trends in field. OA is chronic disease that affects joints their surrounding tissues, leading progressive damage articular cartilage ultimately subchondral bone synovial structures. disabling with an increasing incidence prevalence general population. Modulation immunity inflammation improvement survival differentiation through multidirectional cells potential strategy treatment OA. We searched publications "stem osteoarthritis" Web Science (WOS) core collection database from 1998-2024 summarized results, including year publication, country, institution, author, collaborative network generated using VOSviewer Citespace. In addition, research were identified. Finally, we topics identified future trends. This included 2341 valid papers, trend toward gradual increase number over time. journal highest citations China, University California system, Sekiya I, Osteoarthritis Cartilage, respectively. High-frequency keyword clusters therapy, cells, tissue engineering, extracellular vesicles. Through visualization analysis, elucidated hotspots field past five years. revealed transplantation exosome may be focus research. lays foundation clinical work

Language: Английский

Citations

0

Bone marrow mesenchymal stem cells-derived exosomal miR-24-3p alleviates spinal cord injury by targeting MAPK9 to inhibit the JNK/c-Jun/c-Fos pathway DOI

Dongzi Li,

Xiaoyan Xie, Yuxuan Ou

et al.

Archives of Biochemistry and Biophysics, Journal Year: 2025, Volume and Issue: 769, P. 110434 - 110434

Published: April 22, 2025

Language: Английский

Citations

0

Progression of mesenchymal stem cell regulation on imbalanced microenvironment after spinal cord injury DOI Creative Commons
Yifan Liu, Chenxi Zhao,

Rong Zhang

et al.

Stem Cell Research & Therapy, Journal Year: 2024, Volume and Issue: 15(1)

Published: Oct. 1, 2024

Language: Английский

Citations

3